Perfil
Robert M.
Francomano served as the Chief Commercial Officer at Stemline Therapeutics, Inc. from 2016 to 2021.
He then held the position of Chief Commercial Officer & Senior Vice President at SELLAS Life Sciences Group, Inc. from 2022 to 2024.
Prior to his roles in the pharmaceutical industry, he obtained an undergraduate degree from Siena College and an MBA from the University of Albany.
Antiguos cargos conocidos de Robert Francomano.
| Empresas | Cargo | Fin |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Corporate Officer/Principal | 31/03/2024 |
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2021 |
Formación de Robert Francomano.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Siena College
Siena College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
University of Albany
University of Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Robert Francomano
















